Brenus Pharma raises €11M Series A

Angelor, UI Investissement, Crédit Agricole, Noshaq, Orsa, BIO JAG, Bpifrance, Sambrinvest and Korea Omega Investment Corp are among its investors.

The company develops an off-the-shelf in vivo immunotherapy platform for solid tumors.

Funding history

Jul 20, 2026Series A · This round€11M

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026